1. Academic Validation
  2. An unusually cold active nitroreductase for prodrug activations

An unusually cold active nitroreductase for prodrug activations

  • Bioorg Med Chem. 2012 Jun 1;20(11):3540-50. doi: 10.1016/j.bmc.2012.04.004.
Ayhan Çelik 1 Gülden Yetiş
Affiliations

Affiliation

  • 1 Gebze Institute of Technology, Department of Chemistry, 41400 Gebze-Kocaeli, Turkey. ayhancelik@gyte.edu.tr
Abstract

A set of PCR primers based on the genome sequence were used to clone a gene encoding a hypothetical nitroreductases (named as Ssap-NtrB) from uropathogenic staphylococcus, Staphylococcus saprophyticus strain ATCC 15305, an oxygen insensitive flavoenzyme. Activity studies of the translation product revealed that the nitroreductase catalyses two electron reduction of a nitroaromatic drug of nitrofurazone (NFZ), Cancer prodrugs of CB1954 and SN23862 at optimum temperature of 20 °C together with retaining its maximum activity considerably at 3 °C. The required electrons for such reduction could be supplied by either NADH or NADPH with a small preference for the latter. The gene was engineered for heterologous expression in Escherichia coli, and conditions were found in which the Enzyme was produced in a mostly soluble form. The recombinant Enzyme was purified to homogeneity and physical, spectral and catalytical properties were determined. The findings lead us to propose that Ssap-NtrB represents a novel nitro reductase with an unusual cold active property, which has not been described previously for prodrug activating Enzymes of nitroreductases.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-120313
    Anti-cancer Agent